5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen (2015)
- Authors:
- USP affiliated authors: ZERBINI, MARIA CLAUDIA NOGUEIRA - FM ; PEREIRA, JULIANA - FM
- Unidade: FM
- Subjects: PROGNÓSTICO; FÁRMACOS IMUNOSSUPRESSORES; BIOMARCADORES; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Laboratory investigation
- ISSN: 0023-6837
- Volume/Número/Paginação/Ano: v. 95, suppl. 1, p. 341A, res. 1365, 2015
- Conference titles: Annual Meeting of the United States and Canadian Academy of Pathology
-
ABNT
PAULA, Henrique de et al. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf. Acesso em: 03 maio 2024. , 2015 -
APA
Paula, H. de, Siqueira, S., Pereira, J., Lage, L. A., Xavier, F., Costa, R., & Zerbini, M. C. (2015). 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf -
NLM
Paula H de, Siqueira S, Pereira J, Lage LA, Xavier F, Costa R, Zerbini MC. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen [Internet]. Laboratory investigation. 2015 ; 95 341A.[citado 2024 maio 03 ] Available from: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf -
Vancouver
Paula H de, Siqueira S, Pereira J, Lage LA, Xavier F, Costa R, Zerbini MC. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen [Internet]. Laboratory investigation. 2015 ; 95 341A.[citado 2024 maio 03 ] Available from: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf - Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations
- FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype
- Nodal peripheral T cell lymphoma: A clinical and epidemiological analysis at medicine school of São Paulo University
- Image-guided lymph node core needle biopsy in mycosis fungoides/Sezary syndrome. [Carta]: direct comparison to surgical excision
- Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment
- Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
- Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): retrospective data from a Latin American cohort
- Comparison of two immunohistochemical staining protocols for ALK demonstrates non-inferiority of a 5A4 clone-based protocol versus an ALK01 clone-based protocol for the diagnosis of ALK plus anaplastic large cell lymphoma
- Tumor desmóide torácico em criança
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
